Alan Rosenbloom, MD
Education & Training
BA, Biology, University of Maryland Baltimore County, 1975
MD, University of Maryland, 1980
Residency, Internal Medicine, Kaiser Foundation Hospital, 1983
Postdoctoral Fellow, Biologic Science, Stanford University, 1986
Fellowship, Critical Care Medicine, Presbyterian University Hospital, 1989
Research, Clinical & Academic Interests
- Applying engineering principles to critical care delivery
- Medical education
- Career development and mentorship for critical care trainees
- Development of integrated critical care organizations
Rosenbloom AJ, Linden PK, Dorrance A, Penkosky N, Cohen-Melamed MH, Pinsky MR. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest. 2005 Jun 1;127(6):2139-50.
Rosenbloom AJ, Sipe DM, Weedn VW. Microdialysis of proteins: performance of the CMA/20 probe. Journal of neuroscience methods. 2005 Oct 30;148(2):147-53.
Rosenbloom AJ, Ferris R, Sipe DM, Riddler SA, Connolly NC, Abe K, Whiteside TL. In vitro and in vivo protein sampling by combined microdialysis and ultrafiltration. Journal of immunological methods. 2006 Feb 20;309(1-2):55-68.
Zhong H, Han B, Tourkova IL, Lokshin A, Rosenbloom A, Shurin MR, Shurin GV. Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clinical Cancer Research. 2007 Sep 15;13(18):5455-62.
Attending Physician, Liver Transplant ICU
Resource Intensivist, Critical Care Outreach Service
Chief Medical Officer, Invivomon, Inc. 2009
Chief Executive Officer, Embedded System Microfluidics, LLC 2015